Pharmamarketeer

PolarityTE seeks US FDA nod for OsteoTE, a human cellular and tissue─based product derived from patient's own bone

PolarityTE, Inc, a commercial─stage biotechnology company, announced that it registered OsteoTE with the US Food and Drug Administration (FDA) pursuant to applicable regulations governing human cells, tissues and cellular and tissue─based products (HCT/Ps).

Medhc-fases-banner
Advertentie(s)